A vocal critic of Trump administration actions at the National Institutes of Health was abruptly placed on administrative leave this week.  Jenna Norton, a program official at the National Institute of Diabetes and Digestive and Kidney Disease, was told Thursday she was being immediately placed on administrative leave with full pay. The email notifying her […]

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we learn AbbVie has ended its partnership with Calico, the FDA outlines how bespoke gene-editing treatments can make it through the regulatory pipeline, and more.  The need-to-know this morning Day One Pharmaceuticals […]

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, the alternatives are not particularly appetizing, yes? While you ponder the possibilities, we invite you to join us for […]

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Congress’ failure to pass a spending bill at the end of September led to the expiration of Covid-era policies that expanded the telehealth services covered […]

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of deadlines, online meetings, and phone calls has predictably returned. But what can you do? The world, such as it is, continues to spin. So time to give it a nudge in […]

This is the online version of AASLD in 30 Seconds, the latest from the American Association for the Study of Liver Diseases’s Liver Meeting. Sign up here to get it in your inbox. Happy Sunday from Washington, D.C., where the Liver Meeting is well on its way. We’ll be here thru Tuesday and want to […]

Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Jason Wasserman and Parker Crutchfield. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t […]

For the past few months, CVS Caremark has declined to add a groundbreaking HIV prevention drug from Gilead Sciences to its formularies. Clinical trials showed the twice-a-year injectable, called Yeztugo, was highly effective in preventing the infectious disease, prompting enthusiasm about combating HIV globally. But the pharmacy benefits manager has argued that the $28,000 price tag […]

Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. Johnson & Johnson won U.S. approval to sell the antipsychotic drug Caplyta as a treatment for depression, the company said Thursday, a major step in the drugmaker’s efforts to make the medicine a […]